Characterization of human liver cytochromes P450 by combining the biochemical and proteomic approaches

Toxicology in Vitro

Volumn 20, Issue 6, 2006, Pages 966-974

  Petushkova, N A ^a   Kanaeva, I P ^a   Lisitsa, A V ^a   Sheremetyeva, G F ^a   Zgoda, V G ^a   Samenkova, N F ^a   Karuzina, I I ^a   Archakov, A I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

1D electrophoresis; Cytochromes P450; Human liver; Mass spectrometry; Microsomal oxidation; Microsomes; Quantitation

Indexed keywords

CYTOCHROME B5; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 2C10; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 4A11; CYTOCHROME P450 4F2; DISULFIDE ISOMERASE; ENZYME; FLAVIN MONOOXYGENASE; LIVER ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; BIOTRANSFORMATION; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME SUBSTRATE; FUNCTIONAL PROTEOMICS; HEMANGIOMA; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER MICROSOME; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; STRUCTURAL PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CYTOCHROME P-450 ENZYME SYSTEM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MICROSOMES, LIVER; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33745193692     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.01.005     Document Type: Article

References (42)

1. Alterman M.A., Gogichayeva N.V., and Kornilayev B.A. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based amino acid analysis. Anal. Biochem. 335 2 (2004) 184-191
2. Anzenbacher P., and Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 58 (2001) 737-747
3. Archakov A.I., and Bachmanova G.I. Cytochrome P450 and Active Oxygen (1990), Taylor and Francis, London
4. Archakov A.I., Bachmanova G.I., Blinder L.V., Zhikhareva V.O., Kanaeva I.P., Karyakin A.V., Karuzina I.I., Haitina S.Z., Borovyagin V.L., and Galushchenko I.V. Isolation, analysis and characterization of microsomal ghost fractions. Biokhimia 42 (1977) 100-112
5. Binz P.A., Muller M., and Hoogland C. The molecular scanner: concept and developments. Curr. Opin. Biotechnol. 15 (2004) 17-23
6. Burke M.D., and Mayer R.T. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome 450-binding of phenoxazone and a homologous series of its n-alkyl ether (alkoxyresorufins). Chem. Biol. Interact. 45 (1983) 243-258
7. Cai Z., Chiu J.-F., and He Q.-Yu. Application of proteomics in the study of tumor metastasis. Geno. Prot. Bioinfo. 2 (2004) 152-166
8. French J.S., and Coon M.G. Properties of NAPDH-cytochrome P450 reductase purified from rabbit liver microsomes. Arch. Biochem. Biophys. 195 (1979) 565-577
9. Fridman E., and Pichersky E. Metabolomics, genomics, proteomics, and the identification of enzymes and their substrates and products. Curr. Opin. Plant Biol. 8 13 (2005) 242-248
10. Galeva N., and Alterman M. Comparison of one-dimensional and two dimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes. Proteomics 2 (2002) 713-722
11. Gerber S.A., Rush J., Stemman O., Kirschner M.W., and Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. PNAS 1000 (2003) 6940-6945
12. Govorun V.M., and Archakov A.I. Proteomic technologies in modern biomedical science. Biochemistry (Moscow) 67 (2002) 1109-1123
13. Graham D.R.M., Elliott S.T., and Van Eyk J.E. Broad-based proteomic strategies: a practical guide to proteomics and functional screening. J. Physiol. 563 1 (2005) 1-9
14. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17 (1999) 994-999
15. Han D.K., Eng J., Zhou H., and Aebersold R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 19 (2001) 946-951
16. Hover C.G., and Kulkarni A.P. Lipoxygenase-mediated hydrogen peroxide-dependent N-demethylation of N,N-dimethylaniline and related compounds. Chemico-Biol. Interact. 124 (2000) 191-203
17. Humphery-Smith I., Cordwell S.J., and Blackstock W.P. Proteome analysis of Spiroplasma melliferum (A56) and protein characterisation across species boundaries. Electrophoresis 18 (1997) 1217-1242
18. Ingelman-Sundberg M. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol. Sci. 25 (2004) 193-200
19. Kanaeva I.P., Petushkova N.A., Lokhov P.G., Zgoda V.G., Karuzina I.I., Lisitsa A.V., and Archakov A.I. Proteomic and biochemical analysis of the mouse liver microsomes. Toxicol. in Vitro 19 (2005) 805-812
20. Kiss I., Sandor J., Pajkos G., Bogner B., Hegedus G., and Ember I. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res. 20 (2000) 519-522
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
22. Lafaye A., Junot C., Pereira Y., Lagniel G., Tabet J.-C., Ezan E., and Labarre J. Combined proteome and metabolite-profiling analyses reveal surprising insights into yeast sulfur metabolism. J. Biol. Chem. 280 26 (2005) 24723-24730
23. Lowry O.H., Rosebrough N.I., Farr A.L., and Randall R.I. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
24. Martinez C., Garcia-Martin E., Pizarro R.M., Garcia-Gamito F.J., and Agúndez J.A. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy. Brit. J. Cancer 87 (2002) 681-686
25. Maurice M., Emiliani S., Dalet-Beluche I., Derancourt J., and Lange R. Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsom. Eur. J. Biochem. 200 (2002) 511-517
26. McFadyen M.C., Melvin W.T., and Murray G.I. Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol. Cancer Ther. 3 (2004) 363-371
27. Neuhoff V., Arold N., Taube D., and Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9 (1988) 255-262
28. Nowell S., Sweeney C., Hammons G., Kadlubar F.F., and Lang N.P. CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 377-383
29. Omura T., and Sato R. The carbon monoxide binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. 2. Solubilization, purification and properties. J. Biol. Chem. 239 (1964) 2379-2385
30. P450 Nomenclature Site. Available from: .
31. Parent R., and Beretta L. Proteomics in the study of liver pathology. J. Hepatol. 43 1 (2005) 177-183
32. Pearce R.E., McIntyre C.J., Madan A., Sanzgiri U., Draper A.J., Bullock P.L., Cook D.C., Burton A., Latham J., Nevins C., and Parkinson A. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch. Biochem. Biophys. 331 (1996) 145-169
33. Perkins D.N., Pappin D.D.J., Creasy D.M., and Cottrell J.M. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20 (1999) 3551-3567
34. Rozman D., and Waterman M.R. Lanosterol 14α-demethylase (CYP51) and spermatogenesis. Drug Metab. Dispos. 26 (1998) 1199-1201
35. Santoni V., Molloy M., and Rabilloud T. Membrane proteins and proteomics: un amour impossible. Electrophoresis 21 (2000) 1054-1070
36. Sechi S. A method to identify and simultaneously determine the relative quantities of proteins isolated by gel electrophoresis. Rapid Commun. Mass Spectrom. 16 (2002) 1416-1424
37. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
38. Sivaraman L., Leatham M.P., Yee J., Wilkens L.R., Lau A.F., and Le Marchand L. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res. 54 (1994) 3692-3695
39. Tamasi V., Vereczkey l., Falus A., and Monostory K. Some aspects of interindividual variations in the metabolism of xenobiotics. Inflam. Res. 52 (2003) 322-333
40. Vin H., Tran P., Grenberg G.E., and Fischer V. Methanol solvent may cause increased apparent metabolic instability in in vitro assays. Drug Metab. Dispos. 29 (2001) 185-193
41. Wasinger V.C., Cordwell S.J., Cerpa-Poljak A., Yan J.X., Gooley A.A., Wilkins M.R., Duncan M.W., Harris R., Williams K.L., and Humphery-Smith I. Progress with gene-product mapping of the Mollicutes: Mycoplasma gen. Electrophoresis 16 (1995) 1090-1094
42. Whitoclock J.P.J., and Denison M.S. Induction of cytochrome P450 enzymes that metabolize xenobiotics. In: Ortiz de Montellano P.R. (Ed). Cytochrome P450: Structure, Mechanism, Biochemistry (1995), Plenum Press, New York 391